Does WARFARIN Cause Stent placement? 27 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Stent placement have been filed in association with WARFARIN (Warfarin Sodium). This represents 0.1% of all adverse event reports for WARFARIN.
27
Reports of Stent placement with WARFARIN
0.1%
of all WARFARIN reports
2
Deaths
17
Hospitalizations
How Dangerous Is Stent placement From WARFARIN?
Of the 27 reports, 2 (7.4%) resulted in death, 17 (63.0%) required hospitalization, and 2 (7.4%) were considered life-threatening.
Is Stent placement Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for WARFARIN. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does WARFARIN Cause?
International normalised ratio increased (5,622)
Haemorrhage (2,930)
Gastrointestinal haemorrhage (2,469)
Anaemia (2,409)
Drug interaction (2,056)
Fall (1,702)
Drug ineffective (1,658)
Epistaxis (1,498)
Contusion (1,467)
Dyspnoea (1,374)
What Other Drugs Cause Stent placement?
RANOLAZINE (593)
EVOLOCUMAB (244)
ADALIMUMAB (227)
ROSIGLITAZONE (196)
ETANERCEPT (174)
CLOPIDOGREL BISULFATE (167)
RIVAROXABAN (122)
ASPIRIN (118)
APIXABAN (116)
MACITENTAN (108)